The deletion of CD38, an NAD+ glycohydrolase, in an AD mouse model reduced Aβ plaque load and improved spatial learning, suggesting a role of CD38 inhibition in treating AD [106]. The gene discussed is CD38; the disease is Alzheimer disease.